Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Uli Hacksell currently holds 20,000 shares of ACADIA PHARMACEUTICALS INC (ACAD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Uli Hacksell has been a net seller of ACAD stock. They have purchased $14.9K and sold $11.9M worth of shares.
Uli Hacksell's most recent insider trade was on Jun 9, 2017, when they purchased 10,000 shares at $0.42 per share.
Uli Hacksell serves as Executive at ACADIA PHARMACEUTICALS INC (ACAD). They have executed 124 insider transactions totaling $11.9M over their tenure at the company.
Uli Hacksell holds the position of Executive at ACADIA PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Uli Hacksell has shown a selling trading pattern, with $14.9K in total purchases and $11.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Uli Hacksell was on Feb 17, 2015, when they sold $1.0M worth of ACAD shares. This transaction involved 30,000 shares at $34.30 per share.
Uli Hacksell currently owns 20,000 shares of ACADIA PHARMACEUTICALS INC (ACAD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Uli Hacksell's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Uli Hacksell has 124 Form 4 filings on record as an insider at ACADIA PHARMACEUTICALS INC.
Set alerts for Uli Hacksell and 40,000+ other insiders.